Fulcrum Therapeutics (FULC) Preferred Dividend Payments (2018 - 2019)
Fulcrum Therapeutics (FULC) reported Preferred Dividend Payments of $796000.0 for Q3 2019, down 57.16% year-over-year from $1.9 million in Q3 2018, and down 75.81% quarter-over-quarter from $3.3 million in Q2 2019.
Fulcrum Therapeutics (FULC) Preferred Dividend Payments (2018 - 2019) Analysis & Trends
Fulcrum Therapeutics (FULC) has 2 years of Preferred Dividend Payments data on file, last reported at $796000.0 in Q3 2019.
- Preferred Dividend Payments for Q3 2019 came in at $796000.0, down 57.16% year-over-year; the trailing twelve-month figure through Dec 2019 was $7.1 million (changed N/A YoY), and the FY2019 annual result was $7.1 million, up 8.68% from the prior year.
- Preferred Dividend Payments eased to $796000.0 in Q3 2019 per FULC's latest filing, from $3.3 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $3.3 million in Q2 2019 and troughed at $796000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Fulcrum Therapeutics | 267.90 Mn | 267.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 796,000.00 |
| Jun 30, 2019 | 3.29 Mn |
| Mar 31, 2019 | 3.04 Mn |
| Dec 31, 2018 | 2.82 Mn |
| Sep 30, 2018 | 1.86 Mn |
| Jun 30, 2018 | 1.05 Mn |